2025 ANNUAL CONFERENCE

CME Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint-providership of the Institute for International Medicine and the Kansas Society of Dermatology and Dermatologic Surgery. The Institute for International Medicine is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.

 

The Institute for International Medicine designates this Live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Requirements for Claiming CME:

  1. Register for the conference
  2. Attend educational sessions
  3. Complete the CME evaluation and credit claims form within 4 weeks post conference


Disclosures:

Planning Committee

Isadore Tarantino, MD             Nothing to disclose

Matthew Fink, MD                      Nothing to disclose

Dominic Wu, MD                       Speaker for Bristol Meyers Squibb, Amgen: All relevant financial relationships with ineligible companies mitigated

Fred Loper, MD                          Nothing to disclose

Micah Flint                                 Stock options at Fresenius Medical Care, Outset Medical, and Davita: All relevant financial relationships with ineligible companies mitigated.



Speakers

Leslie Favier, MD                       Nothing to disclose

Katherine Glaser, MD               Nothing to disclose

Minah Singh, MD                      Disclosures: Pfizer (speaker/consultant); Lilly (speaker/consultant); Abbvie (speaker/consultant); Sun Pharma (speaker/consultant);       Arcutis (speaker/consultant).   - All relevant financial relationships with ineligible companies mitigated.

Daniel Tinker, MD                     Disclosures: UCB (speaker); Sanofi (speaker) - All relevant financial relationships with ineligible companies mitigated.

Steven Waldman, MD             Nothing to disclose

Reid Waldman, MD                 Disclosures: Veradermics (Stock options) - All relevant financial relationships with ineligible companies mitigated.  




Questions? Contact us for more information.

Contact Us